Spirea

Biotechnology Research • Cambridge, 1853, United Kingdom • 1-10 Employees

Company overview

Headquarters	Cambridge, 1853, United Kingdom
Phone number	+449817891
Website	spirea.co.uk
NAICS	541714
SIC	873
Employees	1-10
Socials

Key Contacts at Spirea

Myriam Ouberai

Founder / Cso

Mats Lindberg

Owner

Spirea Email Formats

Spirea uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@spirea.co.uk), used 66.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@spirea.co.uk	66.7%
{first initial}.{last name}	j.doe@spirea.co.uk	33.3%

About Spirea

Spirea is at the forefront of revolutionising cancer and beyond with our cutting-edge ELIVATE linker technology. Our innovative approach significantly expands the payload repertoire for antibody-drug conjugates (ADCs), enabling the next generation of targeted therapies. By leveraging ELIVATE’s multivalent capabilities, we optimise therapeutic outcomes, ensuring precise drug delivery and enhanced pharmacokinetics. Our dedicated team of experts is committed to advancing our proprietary ADC pipeline and forming strategic partnerships to maximise the potential of our technology. Join us on our mission to transform patient care and deliver groundbreaking treatments across a wide range of diseases. Explore how Spirea is unlocking the full potential of ADCs at www.spirea.co.uk

Spirea revenue & valuation

Annual revenue	$300,000
Revenue per employee	$38,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$960,000
Total funding	$2,900,000